How hematopoietic stem cells retain their regenerative potential
Researchers found that genetic depletion of cyclophilin A results in stem cells distinctively lacking intrinsically disordered proteins.
List view / Grid view
Researchers found that genetic depletion of cyclophilin A results in stem cells distinctively lacking intrinsically disordered proteins.
Induced NPCs facilitate the creation of patient-specific organoid models and improve identification of nephron targeted drugs.
A synthetic antibody selectively activates the Wnt signalling pathway and directs stem cells to differentiate into neurons.
In this episode, we discuss the current advantages and limitations of using organoids, as well as where the field is heading.
Injections of cardiac spheroids into primate ventricles improved left ventricular ejection after four weeks.
CRISPR has transformed gene editing, but still presents challenges in hard-to-transfect cells, such as pluripotent stem cells and primary cells.1 The key to obtaining successful transfection in these cells lies in innovative workflows. Here Georges Müller, CEO and cofounder of SEED Biosciences, shares his perspective on why focusing on editing…
Transplant recipients of hematopoietic stem cells with a hereditary version of AD developed the disease at an accelerated rate.
Stem-cell based blastocyst models have enabled scientists to redefine the molecular signature and timing of the onset of gastrulation.
The discovery of two proteins that effectively mature hiPSCs into endothelial cells may have a range of research and clinical benefits.
Exhibiting an excellent angiogenic effect, the stem cell therapy could provide an alternative to angioplasty procedures.
Scientists have reported a promising technique, based on somatic cell nuclear transfer, to treat infertility.
Limb bud progenitor cells efficiently generated new cartilage in osteoarthritis patients, which could lead to cartilage replacement therapy.
Using an advanced human heart organoid system, researchers found the contributing factors to the condition and possible therapeutic compounds.
In this Q&A, founder of Scheer Medical Wellness Dr Alexander Scheer shares his insights, discussing the current challenges in stem cell therapy and how these can be addressed, the advancements in delivery techniques, and stem cells’ overall potential in regenerative medicine.
Learn how scientists like you are using Namocell single cell sorters through summaries of seven recent peer-reviewed citations.